Detailed information for compound 102551

Basic information

Technical information
  • TDR Targets ID: 102551
  • Name: 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluo ro-7-(hydroxymethyl)chromen-4-one
  • MW: 336.265 | Formula: C16H11F3N2O3
  • H donors: 3 H acceptors: 2 LogP: 1.78 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCc1c(F)c2oc(cc(=O)c2c(c1F)N)c1ccc(c(c1)F)N
  • InChi: 1S/C16H11F3N2O3/c17-8-3-6(1-2-9(8)20)11-4-10(23)12-15(21)13(18)7(5-22)14(19)16(12)24-11/h1-4,22H,5,20-21H2
  • InChiKey: PLLQRBXKCHPJQL-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-amino-2-(4-amino-3-fluoro-phenyl)-6,8-difluoro-7-(hydroxymethyl)chromen-4-one
  • 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-(hydroxymethyl)-1-benzopyran-4-one
  • 5-azanyl-2-(4-azanyl-3-fluoro-phenyl)-6,8-difluoro-7-(hydroxymethyl)chromen-4-one
  • 5-amino-2-(4-amino-3-fluoro-phenyl)-6,8-difluoro-7-methylol-chromone
  • 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-(hydroxymethyl)-4-chromenone

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Brugia malayi Regulator of G protein signaling domain containing protein 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0179 0.0522 0.1828
Brugia malayi Regulator of G protein signaling domain containing protein 0.0333 0.1039 0.3642
Trypanosoma cruzi trypanothione reductase, putative 0.0045 0.0073 0.5
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0115 0.0307 1
Loa Loa (eye worm) hypothetical protein 0.0333 0.1039 0.3642
Brugia malayi Probable G protein-coupled receptor kinase F19C6.1, putative 0.0333 0.1039 0.3642
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0051 0.0092 1
Echinococcus multilocularis regulator of G protein signaling 3 0.0874 0.2853 0.2853
Echinococcus granulosus A kinase anchor protein 10 mitochondrial 0.0333 0.1039 0.1039
Plasmodium falciparum thioredoxin reductase 0.0045 0.0073 0.9357
Plasmodium vivax glutathione reductase, putative 0.0045 0.0073 0.7907
Schistosoma mansoni regulator of G protein signaling 0.0333 0.1039 0.3642
Echinococcus multilocularis A kinase anchor protein 10, mitochondrial 0.0333 0.1039 0.1039
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0051 0.0092 1
Echinococcus granulosus axis inhibition protein axin 0.0333 0.1039 0.1039
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0115 0.0307 1
Plasmodium vivax thioredoxin reductase, putative 0.0045 0.0073 0.7907
Echinococcus granulosus regulator of G protein signaling 3 0.0874 0.2853 0.2853
Echinococcus multilocularis Regulator of G protein signaling 20 0.0333 0.1039 0.1039
Schistosoma mansoni regulator of G protein signaling 0.0333 0.1039 0.3642
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0141 0.0395 0.0395
Loa Loa (eye worm) hypothetical protein 0.0333 0.1039 0.3642
Echinococcus granulosus axis inhibition protein axin 0.0333 0.1039 0.1039
Schistosoma mansoni lipoxygenase 0.0099 0.0252 0.0884
Loa Loa (eye worm) acetyltransferase 0.0174 0.0504 0.1765
Loa Loa (eye worm) glutathione reductase 0.0045 0.0073 0.0255
Echinococcus granulosus histone acetyltransferase KAT2B 0.0169 0.0487 0.0487
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Loa Loa (eye worm) AGC/GRK/BARK protein kinase 0.0333 0.1039 0.3642
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0103 0.0268 0.8342
Echinococcus granulosus regulator of G protein signaling 7 0.0333 0.1039 0.1039
Echinococcus granulosus regulator of G protein signaling 3 0.0874 0.2853 0.2853
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0103 0.0268 0.8342
Echinococcus multilocularis axis inhibition protein axin 0.0333 0.1039 0.1039
Echinococcus multilocularis muscleblind protein 0.0179 0.0522 0.0522
Schistosoma mansoni serine/threonine protein kinase 0.0333 0.1039 0.3642
Schistosoma mansoni axis inhibition protein axin 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0333 0.1039 0.3642
Plasmodium falciparum glutathione reductase 0.0045 0.0073 0.9357
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0103 0.0268 0.8342
Echinococcus multilocularis axis inhibition protein axin 0.0333 0.1039 0.1039
Loa Loa (eye worm) PXA domain-containing protein 0.0333 0.1039 0.3642
Brugia malayi regulator of G-protein signaling rgs-7 0.0874 0.2853 1
Echinococcus granulosus histone acetyltransferase KAT2B 0.0051 0.0092 0.0092
Echinococcus multilocularis regulator of G protein signaling 7 0.0333 0.1039 0.1039
Leishmania major trypanothione reductase 0.0045 0.0073 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Loa Loa (eye worm) thioredoxin reductase 0.0045 0.0073 0.0255
Echinococcus multilocularis regulator of G protein signaling 3 0.0874 0.2853 0.2853
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Onchocerca volvulus 0.0024 0 0.5
Brugia malayi A-kinase anchor protein 10, precursor 0.0333 0.1039 0.3642
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0174 0.0504 0.1765
Schistosoma mansoni regulator of G protein signaling 0.0874 0.2853 1
Schistosoma mansoni serine/threonine protein kinase 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0874 0.2853 1
Echinococcus multilocularis regulator of G protein signaling 0.0874 0.2853 0.2853
Brugia malayi PXA domain containing protein 0.0333 0.1039 0.3642
Loa Loa (eye worm) RGS-3 protein 0.0333 0.1039 0.3642
Brugia malayi hypothetical protein 0.0333 0.1039 0.3642
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0051 0.0092 1
Entamoeba histolytica hypothetical protein 0.0333 0.1039 1
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0103 0.0268 0.8342
Mycobacterium tuberculosis Probable oxidoreductase 0.0115 0.0307 1
Brugia malayi glutathione reductase 0.0045 0.0073 0.0255
Echinococcus granulosus thioredoxin glutathione reductase 0.0046 0.0075 0.0075
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Echinococcus granulosus Regulator of G protein signaling 20 0.0333 0.1039 0.1039
Plasmodium falciparum histone acetyltransferase GCN5 0.0047 0.0078 1
Brugia malayi Muscleblind-like protein 0.0179 0.0522 0.1828
Schistosoma mansoni lipoxygenase 0.0141 0.0395 0.1385
Brugia malayi Cytochrome P450 family protein 0.0027 0.0012 0.0041
Loa Loa (eye worm) AGC/GRK/GRK protein kinase 0.0333 0.1039 0.3642
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0174 0.0504 0.0504
Brugia malayi regulator of G-protein signaling egl-10 0.0333 0.1039 0.3642
Echinococcus multilocularis thioredoxin glutathione reductase 0.0046 0.0075 0.0075
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Brugia malayi acetyltransferase, GNAT family protein 0.0174 0.0504 0.1765
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0115 0.0307 1
Echinococcus multilocularis regulator of G protein signaling 7 0.0333 0.1039 0.1039
Loa Loa (eye worm) cytochrome P450 family protein 0.0027 0.0012 0.0041
Trichomonas vaginalis conserved hypothetical protein 0.0333 0.1039 1
Echinococcus granulosus regulator of G protein signaling 7 0.0333 0.1039 0.1039
Echinococcus granulosus beta-adrenergic receptor kinase 0.0333 0.1039 0.1039
Echinococcus granulosus arachidonate 5 lipoxygenase 0.0141 0.0395 0.0395
Trichomonas vaginalis regulator of G protein signaling 5, rgs5, putative 0.0333 0.1039 1
Echinococcus granulosus muscleblind protein 0.0179 0.0522 0.0522
Mycobacterium tuberculosis Probable dehydrogenase 0.0103 0.0268 0.8342
Brugia malayi hypothetical protein 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0333 0.1039 0.3642
Echinococcus multilocularis expressed protein 0.3005 1 1
Trypanosoma brucei trypanothione reductase 0.0045 0.0073 0.5
Loa Loa (eye worm) G protein signaling regulator EGL-10 0.0333 0.1039 0.3642
Schistosoma mansoni regulator of G protein signaling 17 19 20 (rgs17 19 20) 0.0333 0.1039 0.3642
Schistosoma mansoni regulator of G protein signaling 0.0333 0.1039 0.3642
Schistosoma mansoni z-protein (S1r protein) 0.0333 0.1039 0.3642
Brugia malayi Thioredoxin reductase 0.0045 0.0073 0.0255
Schistosoma mansoni axis inhibition protein axin 0.0333 0.1039 0.3642
Echinococcus multilocularis beta adrenergic receptor kinase 0.0333 0.1039 0.1039
Echinococcus multilocularis muscleblind protein 1 0.0179 0.0522 0.0522
Entamoeba histolytica hypothetical protein 0.0333 0.1039 1
Schistosoma mansoni regulator of G protein signaling 17 19 20 (rgs17 19 20) 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0333 0.1039 0.3642
Giardia lamblia Histone acetyltransferase GCN5 0.0047 0.0078 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0333 0.1039 0.3642
Schistosoma mansoni regulator of G protein signaling 3 rgs3 0.0333 0.1039 0.3642
Brugia malayi PXA domain containing protein 0.0333 0.1039 0.3642
Loa Loa (eye worm) hypothetical protein 0.0179 0.0522 0.1828
Entamoeba histolytica hypothetical protein 0.0333 0.1039 1
Schistosoma mansoni regulator of G protein signaling 0.0874 0.2853 1
Mycobacterium tuberculosis Probable reductase 0.0103 0.0268 0.8342
Onchocerca volvulus 0.0024 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Body weight change (functional) = 4 % Compound was tested for percentage Body weight change in vivo against MCF-7 cells implanted into Nude Mice, Dosage of the compound 25(mg/kg) ChEMBL. 9622547
Body weight change (functional) = 4 % Compound was tested for percentage Body weight change in vivo against MCF-7 cells implanted into Nude Mice, Dosage of the compound 25(mg/kg) ChEMBL. 9622547
Body weight change (functional) = 6.7 % Compound was tested for percentage Body weight change in vivo against MCF-7 cells implanted into Nude Mice, Dosage of the compound 50(mg/kg) ChEMBL. 9622547
Body weight change (functional) = 6.7 % Compound was tested for percentage Body weight change in vivo against MCF-7 cells implanted into Nude Mice, Dosage of the compound 50(mg/kg) ChEMBL. 9622547
IC50 (functional) = 0.062 uM In vitro cytotoxicity against MCF-7 cell lines, treated for 3 days then uptake of neutral red dye was measured ChEMBL. 9622547
IC50 (functional) = 0.062 uM In vitro cytotoxicity against MCF-7 cell lines, treated for 3 days then uptake of neutral red dye was measured ChEMBL. 9622547
IC50 (functional) = 24 uM In vitro cytotoxicity against HeLa S3 cell lines, treated for 3 days then uptake of neutral red dye was measured ChEMBL. 9622547
IC50 (functional) = 24 uM In vitro cytotoxicity against HeLa S3 cell lines, treated for 3 days then uptake of neutral red dye was measured ChEMBL. 9622547
T/C min (functional) = 1.6 % Ratio of tumor growth rate of the drug-treated group relative to that of the control group at a dose of 50 mg/kg ChEMBL. 9622547
T/C min (functional) = 1.6 % Ratio of tumor growth rate of the drug-treated group relative to that of the control group at a dose of 50 mg/kg ChEMBL. 9622547
T/C min (functional) = 17 % Ratio of tumor growth rate of the drug-treated group relative to that of the control group at a dose of 25 mg/kg ChEMBL. 9622547
T/C min (functional) = 17 % Ratio of tumor growth rate of the drug-treated group relative to that of the control group at a dose of 25 mg/kg ChEMBL. 9622547

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 9622547

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.